Skip to main content
Premium Trial:

Request an Annual Quote

Aspira Granted US Patent for Protein Capture Technology

NEW YORK, Oct. 7-Aspira Biosystems has been granted a patent for its capture agents for proteins, a technique that the company plans to use to develop sequence-specific protein capture arrays.


The patent covers a method developed by Aspira co-founder Chin-Shiou Huang to create cavities for capturing macromolecules. With this method, a template molecule is used to create specific cavities in a solidified material such as mixture of polymers.


Aspira plans to use this technique to profile known and novel proteins in parallel from biological samples.


The U.S. Patent and Trade Office granted the patent on Oct. 1. For further details on the technique, see the patent.


Aspira is a privately held company based in South San Francisco, Calif.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.